← Contracts
PT
Ajuste direto para aquisição de RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] e RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA]
ID 13473462
· Portal BASE
Price
Base Price
€597,008
.00
Effective Price
€79,373
.00
-86.7%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Dates
- Publication
- 18 Feb 2026
- Celebration
- 18 Feb 2026
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 597008.0
- Total effective price
- 79373.0
- Ratio
- 0.133
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.133 outside [0.5, 1.5]
Detected 2026-03-06